Criticaleye recently caught up with Abbas Hussain, President, Emerging Markets at GlaxoSmithKline, to discuss the state of emerging markets and the initial stages of GSK’s low-cost drug plan, a revolutionary scheme set to change the face of the pharmaceutical industry.
Read, watch & listen to some of the latest thought leadership from our Community.
Thomas Knudsen brings a wealth of leadership experience in the global logistics sector to his current role as Chair of international shipping giant Toll Group. He speaks to Criticaleye’s Emily Jones about the role...
Why isn’t sustainability generating more impact for organisations? In this report, Criticaleye Partner, IBM, emphasises that businesses can enhance profitability and growth by embedding sustainability into t...
As businesses recover from the disruptions caused by Covid-19, ensuring a smooth return to the workplace remains high on the list of priorities for many organisations. This report by Yonder Consulting emphasises how ...
Displaying 1 to 3 of 355
We use cookies to improve your experience. By using our site, you agree to our use of cookies.
